Troy Mullane is a Managing Director and Partner at Boston Consulting Group (BCG), based in Philadelphia. He advises biotech and biopharma companies on commercialization, go-to-market strategy, and pricing & market access, with experience across areas including oncology, neuroscience, rare disease, and cell therapy. He also lead’s the firms Talent Acquisition efforts in Philadelphia and Pittsburgh.